Healthcare & Life Sciences

Supporting innovation and enhancing care

FTI Consulting has built an unrivaled, global strategic communications offering to life science and healthcare companies. Our large global team of life sciences and healthcare specialists has the breadth and depth of experience, in pharmaceuticals, biotech, medical devices, digital health and healthcare services, to help you ensure that the right message reaches the right audience at the right time.

We take a holistic view, helping companies to:

  • Develop and defend their reputations
  • Seek to attract and retain the best talent
  • Navigate and inform health and policy agendas
  • Steady themselves for moments of change or periods of growth

We believe the need for our services has never been greater. Trust is at an all-time low. Equity markets are challenging, politics is fragmented, social media is creating a visceral atmosphere.

The Life Sciences and Healthcare industry, in particular, is rife with uncertainty and scrutiny. Companies are increasingly challenged by regulatory demands, financial transactions, and the expectation for innovation and access to care. FTI Consulting works alongside clients to navigate and thrive in the changing marketplace.

We have developed an integrated offering enabling us to provide clients with powerful communications advice on all the core stakeholders and media.

Ben Atwell
Senior Managing Director
EMEA
[email protected]

Lauren Crawford Shaver
Senior Managing Director
Americas
[email protected]

 

Joanne Wong
Senior Managing Director
APAC
[email protected]

Reset
, ,
Beyond Compulsory Licensing: Patent Threats to the U.S. Pharmaceutical Industry Amid an Ongoing Global Pandemic

October 30, 2020 — Compulsory licensing, a tool initially designed to support drug access in emerging markets, is incre...

,
Healthcare providers: A crisis beyond the crisis

September 18, 2020 — A critical look at clinics and hospitals in LatAm, and a perspective on how to manage a crisis that ...

,
Healthcare Ones to Watch: Trends on the EU Agenda

May 7, 2020 — Incoming European Commission President Ursula von der Leyen, a former doctor, has made legislation o...

,
Pharma’s Reputation Crisis: Can Communications Keep Up?

January 13, 2020 — Big pharma has a reputation problem. Over the years, the industry has been criticised for a wide ran...